161 related articles for article (PubMed ID: 29390073)
1. LYG-202 inhibits activation of endothelial cells and angiogenesis through CXCL12/CXCR7 pathway in breast cancer.
Zhao K; Yao Y; Luo X; Lin B; Huang Y; Zhou Y; Li Z; Guo Q; Lu N
Carcinogenesis; 2018 Apr; 39(4):588-600. PubMed ID: 29390073
[TBL] [Abstract][Full Text] [Related]
2. LYG-202 exerts antitumor effect on PI3K/Akt signaling pathway in human breast cancer cells.
Zhao Y; Wang X; Sun Y; Zhou Y; Yin Y; Ding Y; Li Z; Guo Q; Lu N
Apoptosis; 2015 Sep; 20(9):1253-69. PubMed ID: 26153346
[TBL] [Abstract][Full Text] [Related]
3. Activation of GPER suppresses migration and angiogenesis of triple negative breast cancer via inhibition of NF-κB/IL-6 signals.
Liang S; Chen Z; Jiang G; Zhou Y; Liu Q; Su Q; Wei W; Du J; Wang H
Cancer Lett; 2017 Feb; 386():12-23. PubMed ID: 27836733
[TBL] [Abstract][Full Text] [Related]
4. CXCR7 regulates breast tumor metastasis and angiogenesis in vivo and in vitro.
Qian T; Liu Y; Dong Y; Zhang L; Dong Y; Sun Y; Sun D
Mol Med Rep; 2018 Mar; 17(3):3633-3639. PubMed ID: 29257351
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
6. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
[TBL] [Abstract][Full Text] [Related]
7. C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.
Wani N; Nasser MW; Ahirwar DK; Zhao H; Miao Z; Shilo K; Ganju RK
Breast Cancer Res; 2014 May; 16(3):R54. PubMed ID: 24886617
[TBL] [Abstract][Full Text] [Related]
8. CXCL12-CXCR7 axis is important for tumor endothelial cell angiogenic property.
Yamada K; Maishi N; Akiyama K; Towfik Alam M; Ohga N; Kawamoto T; Shindoh M; Takahashi N; Kamiyama T; Hida Y; Taketomi A; Hida K
Int J Cancer; 2015 Dec; 137(12):2825-36. PubMed ID: 26100110
[TBL] [Abstract][Full Text] [Related]
9. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of breast cancer growth and metastasis by a biomimetic peptide.
Lee E; Lee SJ; Koskimaki JE; Han Z; Pandey NB; Popel AS
Sci Rep; 2014 Nov; 4():7139. PubMed ID: 25409905
[TBL] [Abstract][Full Text] [Related]
11. Plumbagin Restrains Hepatocellular Carcinoma Angiogenesis by Stromal Cell-Derived Factor (SDF-1)/CXCR4-CXCR7 Axis.
Zhong J; Li J; Wei J; Huang D; Huo L; Zhao C; Lin Y; Chen W; Wei Y
Med Sci Monit; 2019 Aug; 25():6110-6119. PubMed ID: 31415486
[TBL] [Abstract][Full Text] [Related]
12. The chemokine receptor CXCR7 is a critical regulator for the tumorigenesis and development of papillary thyroid carcinoma by inducing angiogenesis in vitro and in vivo.
Zhang H; Yang L; Teng X; Liu Z; Liu C; Zhang L; Liu Z
Tumour Biol; 2016 Feb; 37(2):2415-23. PubMed ID: 26383519
[TBL] [Abstract][Full Text] [Related]
13. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
Niu G; Sun L; Pei Y; Wang D
Anticancer Agents Med Chem; 2018; 18(4):583-590. PubMed ID: 29065844
[TBL] [Abstract][Full Text] [Related]
14. Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesis.
Choi SH; Lee JY; Suh JS; Park YS; Chung CP; Park YJ
Int J Nanomedicine; 2016; 11():4643-4656. PubMed ID: 27695323
[TBL] [Abstract][Full Text] [Related]
15. Chemokine receptor 7 targets the vascular endothelial growth factor via the AKT/ERK pathway to regulate angiogenesis in colon cancer.
Li X; Wang X; Li Z; Zhang Z; Zhang Y
Cancer Med; 2019 Sep; 8(11):5327-5340. PubMed ID: 31348616
[TBL] [Abstract][Full Text] [Related]
16. CXCL12 enhances angiogenesis through CXCR7 activation in human umbilical vein endothelial cells.
Zhang M; Qiu L; Zhang Y; Xu D; Zheng JC; Jiang L
Sci Rep; 2017 Aug; 7(1):8289. PubMed ID: 28811579
[TBL] [Abstract][Full Text] [Related]
17. Ginsenoside Rd regulates the Akt/mTOR/p70S6K signaling cascade and suppresses angiogenesis and breast tumor growth.
Zhang E; Shi H; Yang L; Wu X; Wang Z
Oncol Rep; 2017 Jul; 38(1):359-367. PubMed ID: 28534996
[TBL] [Abstract][Full Text] [Related]
18. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
Xiong J; Yang Q; Li J; Zhou S
Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
[TBL] [Abstract][Full Text] [Related]
19. Recombinant adeno-associated virus-delivered anginex inhibits angiogenesis and growth of HUVECs by regulating the Akt, JNK and NF-κB signaling pathways.
Ma K; Wang C; Geng Q; Fan Y; Ning J; Yang H; Dong X; Dong D; Guo Y; Wei X; Li E; Wu Y
Oncol Rep; 2016 Jun; 35(6):3505-13. PubMed ID: 27035232
[TBL] [Abstract][Full Text] [Related]
20. SDF-1/CXCR7 axis regulates the proliferation, invasion, adhesion, and angiogenesis of gastric cancer cells.
Ma DM; Luo DX; Zhang J
World J Surg Oncol; 2016 Oct; 14(1):256. PubMed ID: 27716367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
